IQV vs TECH · P/E 23, rev $15.40B vs P/E 65, rev $1.22B
IQVIA Holdings Inc (IQV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IQV and TECH stock pages for the full models.
Not investment advice.